Unlock instant, AI-driven research and patent intelligence for your innovation.
Monocarbonyl curcumin analogue as well as preparation and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of curcumin analogs and curcuminoids, applied in the field of medicine
Active Publication Date: 2021-09-07
THE AFFILIATED HOSPITAL OF TRADITIONAL CHINESE MEDICAL TO SOUTHWEST MEDICAL UNIV +1
View PDF8 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, there are still research gaps in MCACs
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0039] Embodiment 1: Preparation of monocarbonyl curcuminoid analogs CuA-1~CuA-4
[0040] 1) The specific steps for preparing CuA-1~CuA-3 are as follows:
[0041] Dissolve 3.47 parts of aldehyde and 1.735 parts of ketone in 5 mL of saturated hydrogenchloride glacial acetic acid solution, and stir the reaction at room temperature for 12 hours to obtain solution I. After standing for 24 hours, filter solution I and treat it with pure water and absolute ethanol to obtain compound CuA-1, CuA-2 and CuA-3.
[0042] 2) The specific steps for preparing CuA-4 are as follows:
[0043] Take 28.4 parts of 3,4-dihydro-2H-pyran and 14.14 parts of vanillin in 0.16 parts of 4-pyridinium methylbenzenesulfonate dichloromethane suspension and react at room temperature for 12 hours to obtain solution II. After Ⅱconcentration, use saturated NaHCO 3 The solution was washed 3 times and washed with anhydrous Na 2 SO 2 Dry to obtain vanillin protectant;
[0046] Preparation of monocarbonyl curcuminoid analogs CuA-1~CuA-4
[0047] 1) The specific steps for preparing CuA-1~CuA-3 are as follows:
[0048] Dissolve 5.2 parts of aldehyde and 1.735 parts of ketone in 5 mL of saturated hydrogenchloride glacial acetic acid solution, and stir the reaction at room temperature for 12 hours to obtain solution I. After standing for 24 hours, filter solution I and treat it with pure water and absolute ethanol to obtain compound CuA-1, CuA-2 and CuA-3.
[0049] 2) The specific steps for preparing CuA-4 are as follows:
[0050] Take 28.4 parts of 3,4-dihydro-2H-pyran and 14.14 parts of vanillin in 0.16 parts of 4-pyridinium methylbenzenesulfonate dichloromethane suspension and react at room temperature for 12 hours to obtain solution II. After Ⅱconcentration, use saturated NaHCO 3 The solution was washed 3 times and washed with anhydrous Na 2 SO 2 Dry to obtain vanillin protectant;
[0051] Stir the ethanol solution of 5.2 parts of vanilli...
Embodiment 3
[0052] Embodiment 3: Preparation of monocarbonyl curcuminoid analogs CuA-1~CuA-4
[0053] 1) The specific steps for preparing CuA-1~CuA-3 are as follows:
[0054] Dissolve 6.94 parts of aldehyde and 3.47 parts of ketone in 10 mL of saturated hydrogenchloride glacial acetic acid solution, and stir the reaction at room temperature for 24 hours to obtain solution I. After standing for 24 hours, filter solution I and treat it with pure water and absolute ethanol to obtain compound CuA-1, CuA-2 and CuA-3.
[0055] 2) The specific steps for preparing CuA-4 are as follows:
[0056] Take 56.8 parts of 3,4-dihydro-2H-pyran and 28.18 parts of vanillin in 0.32 parts of 4-pyridinium methylbenzenesulfonate dichloromethane suspension and react at room temperature for 24 hours to obtain solution II. After Ⅱconcentration, use saturated NaHCO 3 The solution was washed 3 times and washed with anhydrous Na 2 SO 2 Dry to obtain vanillin protectant;
[0057] Stir the ethanol solution of 6.9...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a monocarbonyl curcumin analogue as well as preparation and an application thereof, the curcumin analogue is represented by a formula I, or pharmaceutically acceptable salts of the curcumin analogue comprise hydrochloride and sulfate, aldehydes and ketones are used as raw materials, monocarbonyl curcumin analogues CuA-1-CuA-3 are designed and synthesized, by designing and synthesizing a monocarbonyl curcumin analogue CuA-4 by taking 3, 4-dihydro-2H-pyran, vanillin, 4-pyridinium methylbenzenesulfonate and 1-methyl-4-piperidone as raw materials, and substituting an unstable beta-dicarbonyl structure with a monocarbonyl group to obtain the more stable monocarbonyl curcumin analogue CuA-1-CuA-4. The monocarbonyl curcumin has better pharmacokinetic behavior and higher anti-tumor activity, and the monocarbonyl curcumin is applied to preparation of drugs for resisting inflammation and treating inflammation-related diseases, Alzheimer's disease, Parkinson's disease, depression, lungcancer, liver cancer, breast cancer, colon cancer and cervical cancer.
Description
technical field [0001] The invention relates to the technical field of medicine, in particular to a monocarbonyl curcuminoid analogue and its preparation and application. Background technique [0002] Natural medicine is an important source of new medicines, and it also provides ideas for the development of new structural medicines. Curcumin (Curcumin, CU), as one of the main active components of turmeric, has attracted widespread attention due to its significant antitumor activity. However, clinical research related to it has not made significant progress, mainly due to the poor stability and low bioavailability of curcumin. The instability and irregular metabolism of CU are mainly caused by the existence of β-dicarbonyl structural unit in its structure. Considering the "neighborhood effect" is also an effective strategy in the design of drug molecules to improve the anti-tumor activity of drugs. Representative monocarbonyl curcumin analogues EF24 and F35 exhibit high se...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.